Table 3.
Consistency between targeted nanopore sequencing test and other confirmatory diagnosis methods.
| confirmatory diagnosis methods | targeted nanopore sequencing | P value | ||
|---|---|---|---|---|
| Positive (N=43) |
Negative (N=5) |
|||
| GeneXpert MTB/RIF | Positive | 27 (100.0%) | 0 (0.0%) | <.001 |
| Negative | 16 (76.2%) | 5 (23.8%) | ||
| Mycobacterium tuberculosis Culture | Positive | 19 (100.0%) | 0 (0.0%) | <.001 |
| Negative | 24 (82.8%) | 5 (17.2%) | ||
| GeneXpert MTB/RIF and/or Mycobacterium tuberculosis Culture | Positive | 30 (100.0%) | 0 (0.0%) | <.001 |
| Negative | 13 (72.2%) | 5 (27.8%) | ||